Annovis Announces Pricing of $15.0 Million Public Offering of Common Stock and Accompanying Warrants
Annovis Bio priced a $15 million public offering of 7.9 million shares and accompanying warrants at $1.90 per unit. The company intends to use the net proceeds for the continued clinical development of its lead compound buntanetap for Alzheimer’s and Parkinson’s disease, as well as for working capital.
Key figures
- Deal Value Usd
- 15000000
- Offering Price
- 1.9
- Shares Offered
- 7895000
- Warrants offered
- 7105500
- Warrant exercise price
- 2.25
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.